药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Methyprylon
Vedolizumab
The risk or severity of adverse effects can be increased when Belinostat is combined with Vedolizumab.
Methyprylon
Obinutuzumab
The risk or severity of adverse effects can be increased when Belinostat is combined with Obinutuzumab.
Methyprylon
Pomalidomide
The risk or severity of adverse effects can be increased when Belinostat is combined with Pomalidomide.
Methyprylon
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Belinostat is combined with Dimethyl fumarate.
Methyprylon
Ponatinib
The risk or severity of adverse effects can be increased when Belinostat is combined with Ponatinib.
Methyprylon
Carfilzomib
The risk or severity of adverse effects can be increased when Belinostat is combined with Carfilzomib.
Methyprylon
Teriflunomide
The risk or severity of adverse effects can be increased when Belinostat is combined with Teriflunomide.
Methyprylon
Belimumab
The risk or severity of adverse effects can be increased when Belinostat is combined with Belimumab.
Methyprylon
Ruxolitinib
The risk or severity of adverse effects can be increased when Belinostat is combined with Ruxolitinib.
Methyprylon
Eribulin
The risk or severity of adverse effects can be increased when Belinostat is combined with Eribulin.
Methyprylon
Wortmannin
The risk or severity of adverse effects can be increased when Belinostat is combined with Wortmannin.
Methyprylon
Pralatrexate
The risk or severity of adverse effects can be increased when Belinostat is combined with Pralatrexate.
Methyprylon
Cabazitaxel
The risk or severity of adverse effects can be increased when Belinostat is combined with Cabazitaxel.
Methyprylon
Bendamustine
The risk or severity of adverse effects can be increased when Belinostat is combined with Bendamustine.
Methyprylon
Belatacept
The risk or severity of adverse effects can be increased when Belinostat is combined with Belatacept.
Methyprylon
Abetimus
The risk or severity of adverse effects can be increased when Belinostat is combined with Abetimus.
Methyprylon
Mepolizumab
The risk or severity of adverse effects can be increased when Belinostat is combined with Mepolizumab.
Methyprylon
Panobinostat
The risk or severity of adverse effects can be increased when Belinostat is combined with Panobinostat.
Methyprylon
Temsirolimus
The risk or severity of adverse effects can be increased when Belinostat is combined with Temsirolimus.
Methyprylon
Human interferon omega-1
The risk or severity of adverse effects can be increased when Belinostat is combined with Human interferon omega-1.